Rockwell Med Inc Stock Price, News & Analysis

Rockwell Medical (RMTI) reported record financial results for Q4 and full-year 2024, achieving profitability on an adjusted EBITDA basis for the first time. The company generated record net sales of $101.5 million in 2024, up 21% from 2023, and record gross profit of $17.5 million, a 101% increase year-over-year.

Q4 2024 highlights include net sales of $24.7 million (12% increase), gross profit of $3.6 million (27% increase), and adjusted EBITDA of $1.4 million (156% improvement). The company ended 2024 with $21.6 million in cash and equivalents.

However, Rockwell's largest customer will transition to another supplier by mid-2025, potentially resulting in a loss of approximately $34 million in revenue. The company is implementing expense reductions and exploring new opportunities, including the launch of a single-use bicarbonate cartridge targeting a $100 million market opportunity.

Rockwell Medical (RMTI) has announced its participation in DialysisTechConneXion42 (DTX42), scheduled for April 1-4, 2025, in Las Vegas, where they will showcase their hemodialysis concentrates portfolio at Booth #112.

The company's product lineup includes:

• CitraPure®: A citric acid-based, acetate-free concentrate available in liquid and dry powder forms
• Dri-Sate®: An acetic acid-based dry powder concentrate
• RenalPure®: An acetic acid-based liquid concentrate
• SteriLyte®: A liquid bicarbonate concentrate for acute care settings

The company also offers a proprietary Dry Acid Concentrate Mixer, FDA-approved bicarbonate cartridges (720g and 900g), and various ancillary products for hemodialysis providers.

Rockwell Medical (RMTI), a global healthcare company specializing in hemodialysis products, has achieved the 'Great Place to Work' certification for the third consecutive year. The certification highlights the company's success in fostering a high-trust culture with strong employee satisfaction.

According to Lesley Spriggs, VP of Human Resources, the recognition reflects the company's progress in creating a workplace environment that promotes innovation, sustainable performance, and business agility. Employees particularly value attributes such as credibility, respect, fairness, pride, and camaraderie, while finding meaning in their work through the positive impact their hemodialysis products have on patients.

Rockwell Medical (Nasdaq: RMTI), a healthcare company focused on hemodialysis products, has scheduled its Q4 and full-year 2024 financial results release for Thursday, March 20, 2025. The company will issue a press release at 6:00am ET, followed by a live conference call and webcast at 8:00am ET.

The earnings call will feature presentations from key executives including President and CEO Mark Strobeck, Ph.D., CFO Jesse Neri, and Chief Commercial Officer Tim Chole. The discussion will cover financial and operational results, followed by a Q&A session.

Rockwell Medical (RMTI) has entered into a distribution services agreement to add single-use bicarbonate cartridges to its hemodialysis product portfolio. The agreement enables RMTI to distribute 510(k) approved bicarbonate cartridges in two sizes (720g and 900g) to dialysis centers, hospital-based outpatient centers, and skilled nursing facilities.

The single-use bicarbonate disposables market represents an approximate $100 million opportunity and is one of the fastest-growing segments within the hemodialysis concentrates market. The company plans to launch the product in late February 2025, leveraging its existing distribution network and transportation subsidiary.

Rockwell Medical (RMTI) has signed a significant product purchase agreement with the world's leading dialysis products and services provider. The agreement covers the supply of SteriLyte®, Rockwell's liquid bicarbonate hemodialysis concentrates product. The partnership is expected to generate over $10 million in net sales for Rockwell in 2025, with incremental price increases in subsequent years.

The agreement has an initial term of three years with the option to extend for two additional one-year periods. Rockwell Medical, as the leading supplier of liquid bicarbonate in the United States, is currently the only manufacturer capable of producing liquid bicarbonate at a scale supporting major U.S.-based dialysis providers.

Rockwell Medical (Nasdaq: RMTI) has promoted Jesse Neri to Chief Financial Officer. Neri, who joined the company in October 2023 as SVP of Finance, brings nearly 25 years of financial leadership experience in both public and private companies. Prior to Rockwell, he served as Executive Director of Finance at Hemavant Sciences and Aruvant Sciences, and as Senior Vice President of Finance at Zyla Life Sciences, where he managed a $80 million revenue operation and led various strategic initiatives including product acquisitions and commercial launches.

Rockwell Medical (RMTI) has announced a partnership with HydroCare, a provider of dialysis water treatment systems, to distribute and install Rockwell's dry acid concentrate mix system in dialysis water rooms. The partnership involves HydroCare purchasing and installing Rockwell's DAMX45 system, which is 510(k) approved for exclusive use with the company's CitraPure® and Dri-Sate® dry acid concentrate powders.

The DAMX45 system features a forced RO water pump that can mix 100 gallons of acid concentrate on-site in three minutes. This collaboration is expected to generate new sales for Rockwell's dry acid hemodialysis concentrates through expanded mixer installations.

Rockwell Medical (Nasdaq: RMTI) has entered into an exclusive distribution agreement with Nephro Group Dialysis Centers, the largest dialysis provider in the Philippines. Under the agreement, Rockwell Medical will be the exclusive supplier of dry hemodialysis concentrates products, including CitraPure® Acid and RenalPure® Bicarbonate. Nephro Group, founded in 1995, has grown to become the Philippines' largest dialysis provider. This expansion adds to Rockwell Medical's international presence, which now spans over 30 countries across North America, South America, Asia, and Africa.